Free Trial

Aptose Biosciences (APTO) SEC Filings & 10K Form

Aptose Biosciences logo

Recent Aptose Biosciences SEC Filings

DateFilerForm TypeView
07/01/2025
7:00 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025
6:30 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2025
7:14 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
3:21 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2025
7:00 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2025
11:15 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2025
4:15 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2025
6:30 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
12:59 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
11:28 AM
Aptose Biosciences (Subject)
Bleichroeder LP (Filed by)
Form SCHEDULE 13G/A
05/08/2025
6:00 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:30 AM
Aptose Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2025
6:30 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2025
3:59 PM
Aptose Biosciences (Filer)
Form DEF 14A
04/23/2025
5:04 AM
Aptose Biosciences (Filer)
Form PRER14A
04/21/2025
4:28 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
4:08 PM
Aptose Biosciences (Filer)
Form PRE 14A
04/03/2025
3:27 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
7:30 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2025
9:46 AM
Aptose Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2025
7:42 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
5:48 PM
Aptose Biosciences (Subject)
Bleichroeder LP (Filed by)
Form SCHEDULE 13G/A
03/24/2025
4:02 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
6:14 PM
Aptose Biosciences (Subject)
Bleichroeder LP (Filed by)
Form SCHEDULE 13G/A
03/20/2025
7:54 PM
Aptose Biosciences (Subject)
Hanmi Pharmaceutical Co., Ltd. (Filed by)
Form SCHEDULE 13D/A
03/20/2025
7:54 PM
Aptose Biosciences (Issuer)
Hanmi Pharmaceutical Co., Ltd. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/17/2025
6:40 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2025
4:12 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
6:40 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
3:30 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
7:26 PM
Aptose Biosciences (Subject)
Bleichroeder LP (Filed by)
Form SCHEDULE 13G
02/13/2025
4:30 PM
Aptose Biosciences (Filer)
Form S-1
Registration statement under Securities Act of 1933  
02/13/2025
4:14 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
3:42 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
6:30 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2025
3:41 PM
Aptose Biosciences (Filer)
Form 424B5
01/28/2025
3:31 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
4:21 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:01 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
6:00 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
5:57 PM
Aptose Biosciences (Filer)
Form DEF 14A
AI Meltdown Imminent: Dump These Stocks Now! (Ad)

If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.

Click here to see the details and learn how to prepare for the next AI revolution
12/27/2024
5:59 PM
Aptose Biosciences (Filer)
Form DEFA14A
12/19/2024
3:10 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
4:03 PM
Aptose Biosciences (Filer)
Form PRE 14A
12/12/2024
9:30 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
11:05 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
5:56 PM
Aptose Biosciences (Issuer)
Rice William G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:27 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2024
5:05 AM
Aptose Biosciences (Filer)
Form 424B4
11/22/2024
7:05 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
11:15 PM
Aptose Biosciences (Filer)
Form EFFECT
11/20/2024
7:00 AM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
2:22 PM
Aptose Biosciences (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G
10/31/2024
5:39 AM
Aptose Biosciences (Filer)
Form S-1/A
10/04/2024
3:15 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
3:15 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:20 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
3:35 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
3:35 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
4:15 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
4:22 PM
Aptose Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
8:43 PM
Aptose Biosciences (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/26/2024
3:30 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
4:00 PM
Aptose Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
10:43 AM
Aptose Biosciences (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:APTO) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners